genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Warfarin
News
Boehringer Refutes British Medical Journal’s Allegations
News
FDA Finally Approves Pfizer & BMS’ Stroke Prevention Drug
Insights
Personalized Medicine Realizing Its Promise
News
FDA Gives Osmetech’s Cystic Fibrosis Genotyping Test a Thumbs Up
News
Metabolon and the Harvard-Partners Healthcare Collaborate to Refine Warfarin Theranostic
News
One of Two Warfarin-Response Genes Can Help Prognosis in the First Week of Dosing
News
Osmetech Licenses Warfarin Biomarker from Marshfield Clinic
News
Nanosphere Obtains FDA Approval for Diagnostic Instrument Related to Blood Coagulation Disorders
News
Gentris Divests Diagnostics Business
News
Clinical Data Releases Pharmacogenetic Warfarin Response Test
Scroll Up
Scroll Up
